Mesoporous Silica for Sustained Drug Release
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 1113
Special Issue Editors
Interests: mesoporous silica nanoparticles; nanocarrier design; intelligent drug delivery system
Special Issue Information
Dear Colleagues,
Mesoporous silica nanoparticles (MSNs), with diversification in shape, size and pore properties, have attracted an extensive attention in biomedical fields due to their distinct morphological features and unique physico-chemical properties. Compared to organic nanocarriers, inorganic rigid MSNs exhibit chemical/thermal stability, and can protect their cargo under broad ranges of temperatures and pHs. On the other hand, the well-developed and tunable pore networks of MSNs provide sufficient space for hosting various therapeutic agents, as well as controlling the drug loading and release kinetics. Furthermore, their internal/external surfaces show amenability of modification with a wide range of functional ligands or intelligent modes (stimuli-responsiveness, targeting, imaging, etc.), presenting a significant potential for drug delivery. In this Special Issue, we invite outstanding researchers around the world active in this field to contribute with research relating the design and synthesis of novel MSNs, sustained/controlled/stimuli-responsiveness/intelligent drug release systems based on MSNs and the drug delivery systems based on MSNs for the diagnosis and treatment of diseases, to provide readers the timely research progress from multiple perspectives.
Dr. Lu Xu
Dr. Heran Li
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesoporous silica nanoparticles
- drug delivery systems
- sustained drug release
- active targeting therapy
- treatment of diseases
